Senner Christopher J.

Quince Therapeutics, Inc. · Director

Senner Christopher J. is listed in public filings as director. This Senner Christopher J. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Quince Therapeutics, Inc. (QNCX), and Exelixis Inc (EXEL). Investors use Senner Christopher J.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Exelixis IncEXEL$1.7M34.9k sharesSellMay 18, 2026$50.00--
Senner Christopher J. | 交易笔记